199
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Epidemiology of Uveitis in a tertiary care centre in Portugal

ORCID Icon, &
Pages 51-57 | Received 20 May 2019, Accepted 26 Jan 2021, Published online: 17 Feb 2021

References

  • Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardisation of Uveitis Nomenclature (SUN) working group. Am J Ophthalmol. 2005;140:509–516. doi:10.1016/j.ajo.2005.03.057.
  • Tsirouki T, Dastiridou A, Symeonidis C, et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2016;28:1–15.
  • Murta JN, Falcão-Reis F, Lopes H et al. Rede nacional de especialidade hospitalar e de referenciação: Oftalmologia. SNS Nov 2016
  • Palmares J, Coutinho MF, Castro-Correia J. Uveitis in Northern Portugal. Curr Eye Res. 1990;9(Suppl:31–4): doi: 10.3109/02713689008999416.
  • Llorenç V, Mesquida M, Sainz de la Maza M, et al. Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization. Acta Ophthalmol. 2015;93(6):561–567. doi:10.1111/aos.12675.
  • Thorne JE, Suhler E, Skup M, et al. Prevalence of Noninfectious Uveitis in the United States: A claims-based analysis. JAMA Ophthalmol. 2016;134(11):1237–1245. doi:10.1001/jamaophthalmol.2016.3229.
  • Engelhard SB, Patel V, Reddy AK. Intermediate uveitis, posterior uveitis, and panuveitis in the Mid-Atlantic USA. Clin Ophthalmol. 2015;25(9):1549–1555. doi:10.2147/OPTH.S89428.
  • Bajwa A, Osmanzada D, Osmanzada S, et al. Epidemiology of uveitis in the mid-Atlantic United States. Clin Ophthalmol. 2015;20(9):889–901. doi:10.2147/OPTH.S80972.
  • Mercanti A, Parolini B, Bonora A, Lequaglie Q, Tomazzoli L. Epidemiology of endogenous uveitis in north-eastern Italy. Analysis of 655 new cases. Acta Ophthalmol Scand. 2001;79(1):64–68. doi:10.1034/j.1600-0420.2001.079001064.x.
  • Jones NP. The Manchester Uveitis Clinic: The first 3000 patients—epidemiology and casemix. Ocul Immunol Inflamm. 2015;23(2):118–126. doi:10.3109/09273948.2013.855799.
  • Jakob E, Reuland MS, Mackensen F, et al. Uveitis subtypes in a German interdisciplinary uveitis center—analysis of 1916 patients. J Rheumatol. 2009;36(1):127–136. doi:10.3899/jrheum.080102.
  • Harman LE, Margo CE, Roetzheim RG. Uveitis: the collaborative diagnostic evaluation. Am Fam Physician. 2014;90(10):711–716.
  • Colmant GR, Kodjikian L, De Bernecourt ADP, et al. Uveitis of unknown etiology: Clinical and outcome features. A retrospective analysis of 355 patients. Ocul Immunol Inflamm. 2019;27(8):1251–1258. doi:10.1080/09273948.2018.1522356.
  • Instituto Nacional de Estatistica, Censos. 2011. Institituto Nacional de Estatística, Statistics Portugal. www.censos.ine.pt. Accessed June 11, 2017.
  • Calderaro A, Peruzzi S, Piccolo G, et al. Laboratory diagnosis of Toxoplasma gondii infection. Int J Med Sci. 2009;6(3):135–136. doi:10.7150/ijms.6.135.
  • Yeung IYL, Popp NA, Chan C-C. The role of gender in uveitis and ocular inflammation. Int Ophthalmol Clin. 2015;55(3):111–131. doi:10.1097/IIO.0000000000000072.
  • Cantini F, Nannini C, Cassarà E, Kaloudi O, Niccoli L. Uveitis in spondyloarthritis: An overview. J Rheumatol Suppl. 2015;93:27–29. doi:10.3899/jrheum.150630.
  • Khairallah M, Accorinti M, Muccioli C, Kahloun R, Kempen JH. Epidemiology of Behçet disease. Ocul Immunol Inflamm. 2012;20(5):324–335. doi:10.3109/09273948.2012.723112.
  • Jamilloux Y, Kodjikian L, Broussolle C, Sève P. Sarcoidosis and uveitis. Autoimmun Rev. 2014;13(8):840–849. doi:10.1016/j.autrev.2014.04.001.
  • Shakarchi FI. Ocular tuberculosis: current perspectives. Clin Ophthalmol. 2015;26(9):2223–2227. doi:10.2147/OPTH.S65254.
  • Jones NP. The Manchester Uveitis Clinic: the first 3000 patients, 2: Uveitis manifestations, complications, medical and surgical management. Ocul Immunol Inflamm. 2015;23(2):127–134. doi:10.3109/09273948.2014.968671.
  • Mandelcorn ED. Infectious causes of posterior uveitis. Can J Ophthalmol. 2013;48(1):31–39. doi:10.1016/j.jcjo.2012.11.013.
  • Jap A, Chee SP. Viral anterior uveitis. Curr Opin Ophthalmol. 2011;22(6):483–488. doi:10.1097/ICU.0b013e32834be021.
  • Kijlstra A, Petersen E. Epidemiology, pathophysiology, and the future of ocular toxoplasmosis. Ocul Immunol Inflamm. 2014;22(2):138–147. doi:10.3109/09273948.2013.823214.
  • Birnbaum AD, Tessler HH, Schultz KL, et al. Epidemiologic relationship between fuchs heterochromic iridocyclitis and the United States rubella vaccination program. Am J Ophthalmol. 2007;144(3):424–428. doi:10.1016/j.ajo.2007.05.026.
  • Suzuki J, Goto H, Komase K, et al. Rubella virus as a possible etiological agent of Fuchs heterochromic iridocyclitis. Graefes Arch Clin Exp Ophthalmol. 2010;248(10):1487–1491. doi:10.1007/s00417-010-1434-6.
  • Damico FM, Kiss S, Young LH. Vogt-Koyanagi-Harada disease. Semin Ophthalmol. 2005;20(3):183–190. doi:10.1080/08820530500232126.
  • Yang P, Zhong Y, Development DL. Evaluation of diagnostic criteria for Vogt-Koyanagi-Harada disease. JAMA Ophthalmol. 2018;136(9):1025–1031. doi:10.1001/jamaophthalmol.2018.2664.
  • Tomkins-Netzer O, Ismetova F, Bar A, Seguin-Greenstein S, Kramer M, Lightman S. Functional outcome of macular edema in different retinal disorders. Prog Retin Eye Res. 2015;48:119–136. doi:10.1016/j.preteyeres.2015.05.002.
  • Davis JL. Ocular syphilis. Curr Opin Ophthalmol. 2014;25(6):513–518. doi:10.1097/ICU.0000000000000099.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.